Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06044610 · ClinicalTrials.gov registry record · NA
Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development
A NA study of Dehydration, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT06044610: Completed NA study of Dehydration, sponsored by PepsiCo Global R&D.
NCT06044610 is a NA study of Dehydration that has completed, run by PepsiCo Global R&D. The registered enrollment target is 32 participants, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06044610, a NA study of Dehydration, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydration or ad libitum fluid intake (GENPOP), 2) an exercise study in moderately active participants in both dehydrated and euhydrated states (EXERCISE). TOI data will be collected alongside standard reference measures of hydration status. This is an exploratory pilot proof of concept study with each subject serving as their own control.
Primary Outcome
Blood flow patterns of the face obtained from the video camera on a smart phone
Conditions Studied
Interventions
- OTHER GENPOP Passive dehydration (75% reduction in fluid intake
- OTHER GENPOP Ad lib fluid intake
- OTHER EXERCISE without fluid replacement
- OTHER EXERCISE with fluid replacement
Study Locations (2)
New York
- PepsiCo R&D, Gatorade Sports Science Institute - Valhalla
Texas
- PepsiCo R&D, Gatorade Sports Science Institute - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2023-11-15 |
| Phase | NA |
What the finished NCT06044610 record still lists
NCT06044610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 4 interventions - of which GENPOP Passive dehydration (75% reduction in fluid intake is the first listed.
NCT06044610 reports a single indexed study location in New York, Texas.
Frequently Asked Questions
What is clinical trial NCT06044610 about?
NCT06044610 is a clinical study titled "Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development". The primary objective of this study is to analyze smart phone-based Transdermal Optical Imaging (TOI) features to develop a model that can discern hypohydration from euhydration status including 1) a small feasibility study for 24-hour data collection in the general population using passive dehydrat...
What is the current status of trial NCT06044610?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-05-08. Estimated completion is 2023-11-15.
What conditions does trial NCT06044610 study?
This clinical trial studies the following conditions: Dehydration.
What interventions are being tested in trial NCT06044610?
The interventions under investigation include: GENPOP Passive dehydration (75% reduction in fluid intake (OTHER), GENPOP Ad lib fluid intake (OTHER), EXERCISE without fluid replacement (OTHER), EXERCISE with fluid replacement (OTHER).
Who is sponsoring clinical trial NCT06044610?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06044610 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dehydration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06044610's enrollment target sits among peer trials
32 9th of 20 higher than 11 of 20 other Dehydration trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
RECRUITING · NA
-
Efficacy of Education Versus Education Plus Prescribed Fluid Intake on Hydration Status in High School Athletes
RECRUITING · NA
-
Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students
RECRUITING · NA
-
Adequate Hydration and Health Outcomes
RECRUITING · NA
-
Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults
ACTIVE NOT RECRUITING · NA
-
Implementing an Intervention to Reduce Heat Stress and Chemical Exposures
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI